Outcomes of Antiviral Retreatment for Immunocompromised Hosts With Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Polymerase Chain Reaction Positivity: A Multicenter Australian Retrospective Case Series
- Author(s)
- Bond, KA; Dendle, C; Guy, S; Slavin, MA; Smibert, O; Ibrahim, N; Kinsella, PM; Morrissey, CO; Moso, MA; Sasadeusz, JJ;
- Details
- Publication Year 2024-08,Volume 11,Issue #8,Page ofae449
- Journal Title
- Open Forum Infectious Diseases
- Publication Type
- Research article
- Abstract
- Outcomes are presented for a multisite retrospective case series, describing a contemporary cohort of 22 immunocompromised patients with persistent coronavirus disease 2019 (COVID-19) polymerase chain reaction positivity who were retreated with antiviral therapy. For those with data available 14 and 30 days after commencement of antiviral therapy, 41% (9 of 22) and 68% (15 of 22), respectively, cleared COVID-19.
- Publisher
- Oxford University Press
- Department(s)
- Infectious Diseases
- Publisher's Version
- https://doi.org/10.1093/ofid/ofae449
- Open Access at Publisher's Site
https://doi.org/10.1093/ofid/ofae449- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-09-10 01:56:37
Last Modified: 2024-09-10 01:58:24